EBS
$1.95
Revenue | $276.6Mn |
Net Profits | $-49.5Mn |
Net Profit Margins | -17.9% |
Emergent Biosolutions Inc’s revenue fell -16.36% since last year same period to $276.6Mn in the Q4 2023. On a quarterly growth basis, Emergent Biosolutions Inc has generated 2.26% jump in its revenue since last 3-months.
Emergent Biosolutions Inc’s net profit jumped 43.75% since last year same period to $-49.5Mn in the Q4 2023. On a quarterly growth basis, Emergent Biosolutions Inc has generated 81.38% jump in its net profits since last 3-months.
Emergent Biosolutions Inc’s net profit margin jumped 32.75% since last year same period to -17.9% in the Q4 2023. On a quarterly growth basis, Emergent Biosolutions Inc has generated 81.79% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.83 |
EPS Estimate Current Year | -0.83 |
Emergent Biosolutions Inc’s earning per share (EPS) estimates for the current quarter stand at -0.83 - a -336.84% fall from last quarter’s estimates.
Emergent Biosolutions Inc’s earning per share (EPS) estimates for the current year stand at -0.83.
Earning Per Share (EPS) | 0 |
Emergent Biosolutions Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2024. This indicates that the Emergent Biosolutions Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-05-07 | -0.83 | 0 | 100% |